Table 2.
SCR (15 eyes) | NC (26 eyes) | β | P-value | |
---|---|---|---|---|
VTI | 0.61 ± 0.36 | 0.42 ± 0.11 | 0.28 | 0.02* |
VD | 0.51 ± 0.06 | 0.50 ± 0.04 | 0.01 | 0.47 |
SSV | 0.32 ± 0.02 | 0.35 ± 0.01 | −0.03 | 0.002* |
SLV | 0.17 ± 0.05 | 0.15 ± 0.03 | 0.02 | 0.31 |
TRBF (μL/min) | 70.42 ± 32.30 | 45.85 ± 11.97 | 26.27 | 0.03* |
Data are presented as mean ± standard deviation; β = effect estimates were derived by mixed model analysis, adjusted for eye and mean arterial pressure. Effect estimates are reported with NC as reference. Statistically significant difference is indicated by an asterisk (*)
SCR sickle cell retinopathy, NC normal control, VTI vessel tortuosity index, VD vessel density, SSV spacing between small vessels, SLV spacing between large vessels, TRBF total retinal blood flow